Related Experiment Video
Updated: Jan 14, 2026
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
Published on: May 12, 2023
The management of croup
1Division of General Academic Pediatrics, Department of Pediatrics, University of Washington School of Medicine, and Children's Hospital and Regional Medical Center, Seattle, Washington 98105-0371, USA.
Insights
Croup treatment focuses on reducing inflammation and symptoms. Glucocorticoids are the primary therapy, with dexamethasone potentially used at higher than necessary doses. Nebulized epinephrine is effective for severe cases.
Area of Science:
- Pediatrics
- Respiratory Medicine
- Pharmacology
Background:
- Croup is a common pediatric respiratory illness characterized by inflammation and narrowing of the larynx's subglottic region, often triggered by viral infections.
- Current treatment strategies aim to alleviate symptoms and reduce inflammation associated with croup.
Purpose of the Study:
- To review the current evidence on the efficacy of various treatments for croup.
- To evaluate the optimal dosing of glucocorticoids and the role of adjunct therapies like epinephrine and heliox.
Main Methods:
- Systematic review of existing literature on croup management.
- Analysis of clinical trial data regarding glucocorticoid efficacy and dosing.
- Assessment of studies on nebulized epinephrine, heliox, and humidified oxygen.
Main Results:
- Glucocorticoids (e.g., dexamethasone) are the cornerstone of croup therapy, effective via oral, parenteral, or nebulized administration.
- The standard oral dexamethasone dose (0.6 mg/kg) may be higher than clinically necessary.
- Nebulized epinephrine (L-epinephrine comparable to racemic) is beneficial for severe croup; heliox shows short-term promise for refractory cases.
Conclusions:
- Glucocorticoids remain the primary treatment for croup, with potential for dose optimization.
- Nebulized epinephrine and heliox offer valuable therapeutic options for specific croup presentations.
- Further research is needed to clarify the role of humidified oxygen in croup management.
Abstract:
Croup is a common paediatric respiratory illness involving inflammation and narrowing of the subglottic region of the larynx, frequently precipitated by viral infections. Treatment is aimed at decreasing symptoms and reducing inflammation. Glucocorticoids are effective by oral, parenteral or nebulized routes, and continue to provide the mainstay of therapy. The common oral dexamethasone dose (0.6 mg/kg) may exceed the dose required for good clinical efficacy. Nebulized epinephrine provides effective additional therapy for more severe cases. L-epinephrine appears to be comparable to racemic epinephrine, although further study is warranted. Limited data suggest that heliox is also effective in the short-term management of refractory croup. The use of humidified oxygen remains controversial, as good data are lacking.
